First evidence of aryl hydrocarbon receptor as a druggable target in hypertension induced by chronic intermittent hypoxia.
Coelho NR, Tomkiewicz C, Correia MJ, Gonçalves-Dias C, Barouki R, Pereira SA, Coumoul X, Monteiro EC. Pharmacol Res. 2020 Sep; 159:104869. Epub 2020 May 19.